Centessa Pharmaceuticals PLC ADR (CNTA) Stock Analysis

Centessa Pharmaceuticals PLC ADR (CNTA) is a publicly traded company in the HEALTHCARE sector. It trades at $39.90, carries a market capitalization of $6.15B. This page summarizes the public market data, fundamentals, and frequently asked questions for CNTA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Centessa Pharmaceuticals PLC ADR currently has a Neutral sentiment score of 0.02.

About Centessa Pharmaceuticals PLC ADR

Centessa Pharmaceuticals PLC is a forward-looking biotechnology company headquartered in Cambridge, UK, dedicated to revolutionizing the therapeutic landscape through its distinct drug discovery and development platform. With a robust pipeline that encompasses multiple therapeutic areas, including oncology and rare diseases, Centessa aims to meet critical unmet medical needs by advancing innovative therapies. The company's strategic integration of cutting-edge scientific research and thorough...

GNG Research Analysis

GNG Research scores Centessa Pharmaceuticals PLC ADR (CNTA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CNTA.

Frequently Asked Questions

Does CNTA pay dividends?

Centessa Pharmaceuticals PLC ADR (CNTA) does not currently pay a regular dividend.

What is CNTA's market cap?

Centessa Pharmaceuticals PLC ADR (CNTA) has a market capitalization of $6.15B with a current stock price of $39.90.